Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Chew, Boon How ^a   Mastura, Ismail ^b   Shariff Ghazali, Sazlina ^a   Lee, Ping Yein ^a   Cheong, Ai Theng ^a   Ahmad, Zaiton ^a   Taher, Sri W ^c   Haniff, Jamaiyah ^d   Mustapha, Feisul I ^e   Bujang, Mohd A ^d  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Klinik Kesihatan Seremban 2   (Malaysia)

^c Klinik Kesihatan Bandar Sungai Petani   (Malaysia)

^d HOSPITAL KUALA LUMPUR   (Malaysia)

^e MINISTRY OF HEALTH   (Malaysia)

Author keywords

Antihypertensive agents; Hypertension; Primary care; Type 2 Diabetes Mellitus

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE DURATION; ETHNICITY; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CARE; REGISTER; RISK FACTOR; UNCONTROLLED BLOOD PRESSURE;

EID: 84861176016     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-54     Document Type: Article

References (49)

1. Williams B. The Hypertension in Diabetes Study (HDS): a catalyst for change. Diabet Med 2008, 25(Suppl 2):13-19.
2. Joffres MR, Hamet P, MacLean DR, L'Italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001, 14(11 Pt 1):1099-1105.
3. Hypertension in Diabetes Study G HDS 1: Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993, 11(3):309-317. 10.1097/00004872-199303000-00012, 8387089, Hypertension in Diabetes Study G.
4. McLean DL, Simpson SH, McAlister FA, Tsuyuki RT. Treatment and blood pressure control in 47,964 people with diabetes and hypertension: A systematic review of observational studies. Can J Cardiol 2006, 22(10):855-860. 10.1016/S0828-282X(06)70304-X, 2569016, 16957803.
5. Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NRC. Cardiovascular Outcomes in Framingham Participants With Diabetes: The Importance of Blood Pressure. Hypertension 2011, 57(5):891-897. 10.1161/HYPERTENSIONAHA.110.162446, 21403089.
6. Williams B. Hypertension in Diabetes 2003, 99-108. Martin Dunitz Publisher, London and New York.
7. Nosadini R. Blood glucose in relation to blood pressure control as risk factors in the progression of renal damage in type 2 diabetes. International Congress Series 2003, 1253:295-299.
8. Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes 2008, 26(2):77-82.
9. Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000, 321(7258):412-419. 10.1136/bmj.321.7258.412, 27455, 10938049.
10. Raikou M, Gray A, Briggs A, Stevens R, Cull C. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. BMJ 1998, 317(7160):720-726. 10.1136/bmj.317.7160.720, 28661, 9732339.
11. Clarke P, Gray A, Briggs A, Stevens R, Matthews D, Holman R. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia 2005, 48(5):868-877. 10.1007/s00125-005-1717-3, 15834550.
12. Ibrahim WN, Aljunid S, Ismail A. Cost of Type 2 Diabetes Mellitus in Selected Developing Countries. Malaysian Journal of Public Health Medicine 2010, 10(2):68-71.
13. Ismail M, Chew BH, Lee PY, Cheong AT, Sazlina SG, Jamaiyah H, Alwi SARS, Wahyu TS, Zaiton A. Control and Treatment Profiles of 70,889 Adult Type 2 Diabetes Mellitus Patients in Malaysia. International Journal of Collaborative Research on Internal Medicine & Public Health 2011, 3(1):98-113.
14. Awin N. A Review of Primary Health Care in Malaysia- A Report for the World Health Organization Western Pacific Region 2000, 6-23. Ministry of Health, Malaysia.
15. Noor Ghani S, Yadav H. Health Care in Malaysia 2008, University of Malaya Press, Kuala Lumpur.
16. Ministry Of Health MOH Drug Formulary, vol. 3/2011 2011, Putrajaya: Ministry of Health, Malaysia, Ministry Of Health.
17. Ministry of Health Malaysia Management of Type 2 Diabetes Mellitus 2009, Technology, Health Section, Assessment Division, Medical Development, Putrajaya, Ministry of Health Malaysia.
18. American Diabetes Association Treatment of Hypertension in Adults With Diabetes. Diabetes Care 2003, 26(suppl 1):s80-s82. American Diabetes Association.
19. Eliasson B, Cederholm J, Nilsson P, Gudbjörnsdóttir S, . for the Steering Committee of the Swedish National Diabetes R The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996-2003. Diabet Med 2005, 22(10):1420-1426. 10.1111/j.1464-5491.2005.01648.x, 16176206, for the Steering Committee of the Swedish National Diabetes R.
20. Sazlina SG, Zaiton A, Ong I. A Clinical Audit on Diabetes Care in Two Urban Public Primary Care Clinics in Malaysia. Malaysian Journal of Medicine and Health Sciences 2010, 6(1):101-109.
21. Sabanayagam C, Shankar A, Saw SM, Tai ES, Lim SC, Lee JJ-M, Wong TY. Prevalence of Diabetes Mellitus, Glycemic Control, and Associated Factors in a Malay Population in Singapore. Asia Pac J Public Health 2009, 21(4):385-398. 10.1177/1010539509343958, 19661105.
22. Howteerakul N, Suwannapong N, Rittichu C, Rawdaree P. Adherence to Regimens and Glycemic Control of Patients with Type 2 Diabetes Attending a Tertiary Hospital Clinic. Asia Pac J Public Health 2007, 19(1):43-49. 10.1177/10105395070190010901, 17784659.
23. Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, et al. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J 2006, 27(24):2982-2988. 10.1093/eurheartj/ehl403, 17145722.
24. Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005, 365(9457):434-441.
25. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus. Diabetes Care 2007, 30(1):162-172. 10.2337/dc07-9917, 17192355.
26. Boer-Martins L, Figueiredo V, Demacq C, Martins L, Consolin-Colombo F, Figueiredo M, Cannavan F, Moreno H. Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients. Cardiovasc Diabetol 2011, 10(1):24. 10.1186/1475-2840-10-24, 3072316, 21426540.
27. Leosdottir M, Willenheimer R, Persson M, Nilsson P. The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmo Preventive Project. Cardiovasc Diabetol 2011, 10(1):118. 10.1186/1475-2840-10-118, 3270001, 22204568.
28. Duggirala MK, Cuddihy RM, Cuddihy M-T, Naessens JM, Cha SS, Mandrekar JN, Leibson CL. Predictors of Blood Pressure Control in Patients With Diabetes and Hypertension Seen in Primary Care Clinics. Am J Hypertens 2005, 18(6):833-838. 10.1016/j.amjhyper.2004.12.016, 15925744.
29. Gudbjörnsdottir S, Eeg-Olofsson K, Cederholm J, Zethelius B, Eliasson B, Nilsson PM, . on behalf of the Swedish National Diabetes R Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Diabet Med 2009, 26(1):53-60. 10.1111/j.1464-5491.2008.02633.x, 19125761, on behalf of the Swedish National Diabetes R.
30. Konzem SL, Devore VS, Bauer DW. Controlling hypertension in patients with diabetes. Am Fam Physician 2002, 66(7):1209-1214.
31. Neldam S, Lang M, Jones R, . On behalf of the T-I Telmisartan and Amlodipine Single-Pill Combinations vs Amlodipine Monotherapy for Superior Blood Pressure Lowering and Improved Tolerability in Patients With Uncontrolled Hypertension: Results of the TEAMSTA-5 Study. J Clin Hypertens 2011, 13(7):459-466. On behalf of the T-I.
32. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005, 366(9489):895-906. 10.1016/S0140-6736(05)67185-1, 16154016.
33. Abdulameer SA, Sahib MN, Aziz NA, Hassan Y, Alrazzaq HA, Ismail O. Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: a pilot study. Patient Prefer Adherence 2012, 6:101-108. 3277800, 22346346.
34. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med 2010, 362(17):1575-1585.
35. Tan MY, Magarey JM, Chee SS, Lee LF, Tan MH. A brief structured education programme enhances self-care practices and improves glycaemic control in Malaysians with poorly controlled diabetes. Health Educ Res 2011, 26(5):896-907. 10.1093/her/cyr047, 21715653.
36. Grant RW, Cagliero E, Dubey AK, Gildesgame C, Chueh HC, Barry MJ, Singer DE, Nathan DM, Meigs JB. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med 2004, 21(2):150-155. 10.1111/j.1464-5491.2004.01095.x, 14984450.
37. Rohana D, Wan Norlida WI, Nor Azwany Y, Mazlan A, Zawiya D, Che Kamaludin CA, Cs CG. Economic Evaluation of Type 2 Diabetes Management at the Malaysian Ministry of Health Primary Care Clinics, in Machang, Kelantan. Malaysian Journal of Public Health Medicine 2007, 7(1):5-13.
38. National Healthcare Establishments & Workforce Statistics ( Primary Care ) 2008-2009 2011, Clinical Research Centre, Ministry of Health, Malaysia, Kuala Lumpur.
39. Elasy T. Improving Diabetes Outcomes: Beyond Glucocentricity. Clin Diabetes 2008, 26(1):1-2.
40. Putnam W, Lawson B, Buhariwalla F, Goodfellow M, Goodine R, Hall J, Lacey K, MacDonald I, Burge F, Natarajan N, et al. Hypertension and type 2 diabetes: What family physicians can do to improve control of blood pressure - an observational study. BMC Fam Pract 2011, 12(1):86. 10.1186/1471-2296-12-86, 3163533, 21834976.
41. Chan GC, Teng CL. Primary care doctors' perceptions towards evidence-based medicine in Melaka State: a questionnaire study. Med J Malaysia 2005, 60(2):130-133.
42. Kaissi AA, Parchman M. Organizational Factors Associated With Self-management Behaviors in Diabetes Primary Care Clinics. Diabetes Educ 2009, 35(5):843-850. 10.1177/0145721709342901, 19783769.
43. Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H, . for the CIII Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ 2009, 181(1-2):37-44. 2704409, 19581618, for the CIII.
44. Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA. Effect of Adding Pharmacists to Primary Care Teams on Blood Pressure Control in Patients With Type 2 Diabetes. Diabetes Care 2011, 34(1):20-26. 10.2337/dc10-1294, 3005466, 20929988.
45. Simkin-Silverman LR, Conroy MB, Bhargava T, McTigue KM. Development of an Online Diabetes Prevention Lifestyle Intervention Coaching Protocol for Use in Primary Care Practice. Diabetes Educ 2011, 37(2):263-268. 10.1177/0145721710396587, 21421991.
46. Lai P, Chua SS, Tan CH, Chan SP. Validation of the Diabetes, Hypertension and Hyperlipidemia (DHL) knowledge instrument in Malaysia. BMC Med Res Methodol 2012, 12(1):18. 10.1186/1471-2288-12-18, 3352255, 22361093.
47. BoonHow C, Theng CA, Ismail M, Rahman SASA. Diabetic Hypertensive Control And Treatment: A Descriptive Report From The Audit Diabetes Control And Management (ADCM) Registry. Malaysian Family Physician 2010, 5(3):134-138.
48. Larrañaga I, Arteagoitia JM, Rodriguez JL, Gonzalez F, Esnaola S, Piniés JA, . the Sentinel Practice Network of the Basque C Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain. Diabet Med 2005, 22(8):1047-1053. 10.1111/j.1464-5491.2005.01598.x, 16026371, the Sentinel Practice Network of the Basque C.
49. Gallo JJ, Bogner HR, Morales KH, Post EP, Ten Have T, Bruce ML. Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry 2005, 13(9):748-755. 2792894, 16166403.